These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7670051)

  • 21. [Adenylate cyclase. A possible factor in the pathogenicity of Yersinia pestis].
    Michankin BN; Chevchenko LA; Asseeva LE
    Bull Soc Pathol Exot; 1992; 85(1):17-21. PubMed ID: 1596952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Resistance to plague of mice experimentally infected with "Yersinia enterocolitica" (author's transl)].
    Alonso JM; Joseph-François A; Mazigh D; Bercovier H; Mollaret HH
    Ann Microbiol (Paris); 1978; 129B(2):203-7. PubMed ID: 718023
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of histamine receptors of mouse and guinea pig peritoneal leukocytes in the pathogenetic effect of Yersinia pestis adenylate cyclase].
    Mishan'kin BN; Aseeva LE; Shevchenko LA; Rublev BD
    Biull Eksp Biol Med; 1992 Jun; 113(6):629-31. PubMed ID: 1446035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of the Yersinia plasmid of calcium-dependency in the formation of the plague immunity].
    Byvalov AA; Darmov IV; Marakulin IV; Obrosova AG; Pogorel'skiĭ IP
    Mol Gen Mikrobiol Virusol; 2005; (4):25-9. PubMed ID: 16334222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive.
    Brandler P; Saikh KU; Heath D; Friedlander A; Ulrich RG
    J Immunol; 1998 Oct; 161(8):4195-200. PubMed ID: 9780193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-scale purification of the F1 antigen of Yersinia pestis.
    Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R
    Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865
    [No Abstract]   [Full Text] [Related]  

  • 28. [The characteristics of the action of the capsular antigen of Yersinia pestis on cells from plague-susceptible and -insusceptible rodents].
    Kagramanov VS; Aseeva LE; Varivoda TIu
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):13-6. PubMed ID: 10851982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The protective activity of the adhesion pili of Yersinia pestis].
    Vodop'ianov SO; Rybianets AA; Verkina LM; Romanova LV; Sorokina TB; Mishan'kin BN
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):26-9. PubMed ID: 8525726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis.
    Welkos SL; Davis KM; Pitt LM; Worsham PL; Freidlander AM
    Contrib Microbiol Immunol; 1995; 13():299-305. PubMed ID: 8833858
    [No Abstract]   [Full Text] [Related]  

  • 31. Construction of defined F1 negative mutants of virulent Yersinia pestis.
    Worsham PL; Stein MP; Welkos SL
    Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
    [No Abstract]   [Full Text] [Related]  

  • 32. [Protective activity of the recombinant strain Salmonella minnesota R595/GSA, synthesizing the plague capsule antigen in experimental plague in mice].
    Gremiakova TA; Stepanshina VN; Korobova OV; Anisimov GA
    Mol Gen Mikrobiol Virusol; 1994; (1):23-6. PubMed ID: 8133846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of a vaccinal strain of the plague microbe on C3-receptor expression on the surfaces of peritoneal and alveolar macrophages].
    Vasil'eva GI; Tkachenko LN; Doroshenko EP; Gamleshko KhP; Balatskaia TA
    Mikrobiol Z; 1994; 56(4):25-9. PubMed ID: 9181978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
    Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant fraction 1 protein of Yersinia pestis activates murine peritoneal macrophages in vitro.
    Sodhi A; Sharma RK; Batra HV; Tuteja U
    Cell Immunol; 2004 May; 229(1):52-61. PubMed ID: 15331328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunologic activity of the "murine" toxin of the plague microbe in experiments on animals].
    Evstigneev VI; Chicherin IuV; Byvalov AA; Pautov VN; Dodonov NP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Mar; (3):39-42. PubMed ID: 7245966
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of the Yersinia pestis capsular antigen on the 5'-nucleotidase activity of macrophages from mice of different strains].
    Kirillicheva GB; Naumov AV; Taranenko TM; Serdobintsev LN; Solov'eva MS; Baturina IG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):105-6. PubMed ID: 8079523
    [No Abstract]   [Full Text] [Related]  

  • 38. [Monokine-producing activity of human monocyte-like cell line U937 induced by Yersinia pestis EV antigens].
    Ivanova IA; Vasil'eva GI; Kiseleva AK; Doroshenko EP; Bespalova IA
    Tsitologiia; 2001; 43(12):1112-4. PubMed ID: 11881148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The cytokine-inducing activity of the Yersinia pestis "murine" toxin].
    Vasil'eva GI; Mishan'kin MB; Kozlovskiĭ VN; Verkina LM; Mishan'kin BN
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):61-4. PubMed ID: 9532689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Heterogenetic antigens of plague and cholera microbes, similar to antigens of human and animal tissues].
    Zhukov-Berezhnilov NN; Adamov AK; Anisimov PI; Bochko GM; Podoplelov II
    Biull Eksp Biol Med; 1972 Apr; 73(4):63-5. PubMed ID: 4623967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.